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Abstract – Background. We present a
retrospective study of a series of 40 patients over the
age of 75 operated for an asymptomatic carotid
stenosis. The results were evaluated during an
average of 3 years of follow-up. Material and
method. The study is retrospective and monocentric.
The series includes 40 patients aged over 75 years
and with an average age of 78.5 years (range 75-82).
Patients underwent surgery for an asymptomatic
carotid stenosis of more than 80%. The technique in
all case was a carotid endarterectomy. Results. There
have been no postoperative deaths or neurological
adverse events. During an average follow-up of 3
years, there was one death secondary to colon
cancer. However, 5 patients were lost to follow-up.
Conclusion: Carotid surgery in elderly patients may
have a benefit. However, our study has
shortcomings. It is retrospective and the patient
cohort is reduced. A randomized, prospective study,
comparing surgery or angioplasty with the best
medical treatment, is necessary to choose the most
effective and safest treatment to offer to an elderly
patient with asymptomatic carotid stenosis.
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I. INTRODUCTION
Stroke is the leading cause of non-traumatic
acquired disability. 15-20% of strokes are linked to
atheromatous carotid stenosis. The prevalence of carotid
stenosis increases with age, especially after age 75 and
especially among men.
Carotid stenosis are asymptomatic if no
hemispheric or retinal symptoms have appeared in the 6
months preceding the discovery of the stenosis.
Asymptomatic carotid stenosis (ACS) accounts for about
¾ of all carotid lesions. The goal of treating carotid
stenosis is to prevent a stroke. While carotid surgery is
recommended in the elderly patients in cases of
symptomatic carotid stenosis, that of ACS in patients over

75 years old, even when tight, remains subject to many
controversies. Indeed, the debate, concerning the benefit
to be expected from a surgical procedure or a possible
angioplasty procedure, is not yet closed. The aim of our
study, through a retrospective evaluation of the results of
carotid endarterectomy (CEA) of a series of 40 patients
aged over 75 years, is to answer the question of the
usefulness or not, of operate the tight ACS affecting the
elderly population.
II. MATERIAL AND METHOD
We performed a retrospective monocentric
analysis of a series of 40 patients with an ACS of more
than 80%. All the patients were more than 75 years old
and had a life expectancy of more than 4 years. This series
includes 28 men and 12 women. The mean age was 78.5
years (range 75-82).
ACS was constantly discovered during the
assessment of atheromatous disease. High blood pressure
was present in 60% of patients, diabetes in 35% of cases, a
history of smoking in 50% of cases and dyslipidemia in
40% of cases.
Based on the risk score described by Wallaert [1],
we estimated that 34 patients (85%) could have a life
expectancy of more than 5 years and 6 patients (15%), a
life expectancy of at least four years. Duplex ultrasound,
performed in all cases, allowed the measurement of the
degree of stenosis and the evaluation of the characteristics
of the atherosclerotic plaque.
The main criterion for inclusion of patients in the
series is a degree of stenosis greater than 80% measured
by the maximum systolic velocity at the site of the
stenosis which must have been greater than 250 cm / s.
The second inclusion criterion was the ultrasound
characteristics of a possibly dangerous and unstable
plaque. CT angiography or angio-MRI of the brain and
supra-aortic trunks was requested for all patients. All our
patients were operated under general anesthesia. The
operative
technique
consisted
of
an
open
thromboendarterectomy in 34 patients, 15 of whom were
closed with a patch and 19 without patch. One patient was
treated with a homolateral carotid-carotid bypass.
III. RESULTS
The mean clamping time was 22 minutes. The
average hospital stay was 4 days (range 3-7). 3 patients

had a minor cervical hematoma. 02 patients had regressive
cognitive impairment in 2 days.
There were no neurological events or deaths
during the first 30 post-operative days. During an average
follow-up of 3 years (range 0.5 and 5), 5 patients were lost
to follow-up. One patient died, 4 years later, secondary to
a colon cancer and another patient suffered from a state of
dementia. The rest of the patients followed had no
ischemic stroke.

IV. DISCUSSION
In some countries, such as Denmark, an ACS is
very little operated, while in other countries like the
United States, the majority of the carotid stenosis
operated, is asymptomatic [2]. Indeed, some authors
believe that revascularization is not a solution in ACS, all
ages combined [3].
The results of our study are generally good and
encouraging. However, the study has flaws: it is
retrospective, the cohort is small, the number of people
lost to follow-up is relatively large and finally, no
comparison with a group of patients ,treated with best
medical treatment ,was carried out. These shyness mean
that the conclusions of our study could not lead us to
specify the therapeutic indications to be adopted in real
life with respect to ACS in elderly patients. Thus, in our
institution we refer to published randomized studies and to
the various recommendations of learned societies for the
choice of the best therapeutic option to offer to our elderly
patients with ACS.
An older person is more likely to have a stroke
than a young subject. An older person's stroke is more
disabling and with a higher risk of death than that which
occurs in a young subject [4]. However, research of ACS
is not routinely recommended in the elderly [5]. It should
be noted that prospective randomized studies have often
excluded patients over the age of 75 with ACS. Indeed,
age has always been considered a surgical risk factor.
However, at the end of our study, we noted that age did
not increase the operative risk of carotid surgery. This
observation was also underlined in the NASCET study,
but in patients with symptomatic carotid stenosis [6]. A
meta-analysis published by Ballota, collecting 845 CEA
performed in patients over 75 years old but symptomatic,
found an average cumulative post-operative mortality and
neurological morbidity rate of 3.3% [7]. Another
confirmation comes from a Canadian study which shows
that carotid surgery in elderly patients, even
asymptomatic, is not accompanied by an increase in
mortality and neurological morbidity but that the postoperative
complications,
particularly
myocardial
infarction, should consider a reflection on the advisability
of performing CEA in an elderly patient [8].
Thus, the question of the best treatment arises
with more reflection when the carotid stenosis is
asymptomatic. Optimal medical treatment, including

correction of risk factors, one or two antiplatelet agents, a
statin and controlled physical activity, has significantly
reduced the risk of stroke in patients with ACS. The
annual rate of stroke of ACS in patients on optimal
medical treatment is currently around 0.5% [2]. The
ACST-1 study, which compared a group of patients
treated with CEA to another group treated medically, did
not find a benefit in terms of prevention of stroke, in
patients over 75 years old with ACS [9]. So, what elderly
patient can benefit from a carotid interventional
procedure? We believe ,that under certain conditions, an
elderly
patient
should
benefit
from
carotid
revascularization if his stenosis is very tight, by more than
80%, or if it progresses rapidly, if his life expectancy
exceeds 4 years, if he is no cognitive impairment, if the
plaque ultrasound structure raises the risk of an embolic
risk (irregular or echolucent plaque) or if the MRI shows
an intra-plaque hemorrhage, or if the transcranial doppler
reveals transient signals of high intensity from
spontaneous micro-embolization or if a silent ipsilateral
cerebral infarction is found or a decrease in vascular
reactivity [9]. If the therapeutic indication is selected,
what type of anesthesia will be made for the realization of
carotid revascularization? Locoregional anesthesia is often
recommended to operate on elderly patients, but in our
series, all of our patients had general anesthesia without
this being harmful. A final question is that of the choice of
technique: endarterectomy or carotid angioplastystenting(CAS)? Stanziale compared carotid angioplasty in
patients over the age of 80 to those under the age of 80
and concluded that the risk of angioplasty is much higher
in the elderly than in the young [10] Results, which
contradict Stanziale's conclusion, are reported by another
study that compared a group of 129 patients treated with
CAS to another group of 45 patients treated with CEA. All
patients were over 80 years of age. 80% of patients were
asymptomatic. There were 2.3% death and stroke at 30
days in the group treated by CAS and 4.4% in the group
treated by CEA. The author of this study underlines that if
the CAS is carried out by an experienced team,
octogenarians can benefit from it with more safety [11].
The complex arterial anatomy of the elderly may explain
the high rate of complications after CAS in patients over
80 years of age [12].
In order to reduce the rate of neurological
complications after CAS, trans-carotid angioplasty has
developed and has become safer and more effective in
octogenarians, whether symptomatic or asymptomatic, as
pointed out in an article published by Ghamraoui which
found that the clamping procedure and time were short
and that the hospital stay was also short. [13]. However,
whatever the technique chosen, open surgery or
angioplasty-stenting, it must be performed by a trained
team which has an activity whose combined mortality and
neurological mortality rate is less than 3%. [14].

V. CONCLUSION

The individual risk of stroke in ACS is very low,
even in cases of high stenosis, and the absolute benefit of
surgery in these cases is very low. Patients were,
theoretically, more surgical risk factors than young
patients. However, on condition of making a rigorous
selection, a patient over 75 years old, with few wellcontrolled comorbidities and a good life expectancy, can
benefit from an interventional procedure in case of tight
ACS. The decision will be made on a case-by-case basis
by a multidisciplinary team. Patient information is
essential. We believe that the safest technique for an
elderly patient is trans-carotid angioplasty. However, in
order to confirm this therapeutic option, a randomized
prospective study on a large series is necessary.
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